Shares of Blend Labs, Inc. (NYSE:BLND – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $4.79.
A number of research firms recently commented on BLND. Keefe, Bruyette & Woods boosted their target price on Blend Labs from $3.25 to $3.85 and gave the stock a “market perform” rating in a research report on Thursday, November 7th. Canaccord Genuity Group increased their target price on Blend Labs from $4.75 to $5.75 and gave the company a “buy” rating in a research report on Thursday, November 7th. Wells Fargo & Company boosted their price target on shares of Blend Labs from $4.50 to $6.50 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. The Goldman Sachs Group increased their price objective on shares of Blend Labs from $3.40 to $3.90 and gave the company a “buy” rating in a research report on Thursday, November 7th. Finally, UBS Group upped their target price on shares of Blend Labs from $3.00 to $4.00 and gave the company a “neutral” rating in a research report on Wednesday, October 23rd.
Read Our Latest Research Report on Blend Labs
Blend Labs Stock Performance
Insiders Place Their Bets
In related news, Director Timothy J. Mayopoulos sold 42,721 shares of the firm’s stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $5.00, for a total value of $213,605.00. Following the transaction, the director now owns 387,620 shares of the company’s stock, valued at $1,938,100. This trade represents a 9.93 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Winnie Ling sold 10,000 shares of the business’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $4.06, for a total transaction of $40,600.00. Following the completion of the sale, the insider now directly owns 279,169 shares of the company’s stock, valued at approximately $1,133,426.14. This trade represents a 3.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 181,838 shares of company stock valued at $899,144 over the last 90 days. Insiders own 13.21% of the company’s stock.
Institutional Trading of Blend Labs
A number of large investors have recently modified their holdings of the company. FMR LLC raised its position in Blend Labs by 15.8% during the 3rd quarter. FMR LLC now owns 26,148 shares of the company’s stock valued at $98,000 after purchasing an additional 3,576 shares in the last quarter. ClariVest Asset Management LLC increased its stake in shares of Blend Labs by 2.9% during the second quarter. ClariVest Asset Management LLC now owns 252,059 shares of the company’s stock valued at $595,000 after buying an additional 6,988 shares during the period. Dark Forest Capital Management LP bought a new stake in shares of Blend Labs in the second quarter valued at about $31,000. Xponance Inc. purchased a new stake in Blend Labs in the second quarter worth about $35,000. Finally, EP Wealth Advisors LLC grew its holdings in Blend Labs by 8.2% during the 2nd quarter. EP Wealth Advisors LLC now owns 212,841 shares of the company’s stock worth $502,000 after acquiring an additional 16,084 shares in the last quarter. Hedge funds and other institutional investors own 52.56% of the company’s stock.
About Blend Labs
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Recommended Stories
- Five stocks we like better than Blend Labs
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- With Risk Tolerance, One Size Does Not Fit All
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 5 Top Rated Dividend Stocks to Consider
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.